CN104435130A - Application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug - Google Patents
Application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug Download PDFInfo
- Publication number
- CN104435130A CN104435130A CN201410761495.XA CN201410761495A CN104435130A CN 104435130 A CN104435130 A CN 104435130A CN 201410761495 A CN201410761495 A CN 201410761495A CN 104435130 A CN104435130 A CN 104435130A
- Authority
- CN
- China
- Prior art keywords
- eucalyptus
- application
- guanglin
- grandis
- leaves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug. The invention provides an application method of the essential oil from leaves of the eucalyptus urophylla E.grandis, Guanglin 9 in a pioneering manner.
Description
Technical field
The present invention relates to the application process of a kind of wide woods No. nine eucalyptus leaf essential oils.
Background technology
Eucalyptus originates in Australia, all has plantation on Yunnan Province of China, Guangdong, Guangxi and Hainan and other places.Research shows that eucalyptus leaf essential oil has antibacterial, antioxidation and the biological activity such as to walk quickly and keep away.Along with growth in the living standard and the attention to environment, people are also more and more obvious to the demand of the Natural antioxidant, repellant and antibacterial, and eucalyptus leaf essential oil have natural, to harm the little and easy advantage such as decomposition in the environment, it has a extensive future.
Wide woods No. nine eucalyptus globuluss (Eucalyptus urophylla × E.grandis, Guanglin 9), have fast-growing, the good characteristic such as dry straight, cold-resistant, be Guangxi particularly in osmanthus, the leading seeds of backlands district, osmanthus eucalyptus plantation.The branch and leaf of wide woods No. nine eucalyptus globuluss are luxuriant, are rich in quintessence oil in blade, and the exploitation for wide woods No. nine eucalyptus oils are the important means improving Folium eucalypti globueli (Eucalyptus globulus Labill.) comprehensive utilization value.At present, the value of No. nine eucalyptus globuluss in Guangxi is mainly timber, and Folium eucalypti globueli (Eucalyptus globulus Labill.) is only used as fuel, and the research and development therefore in the urgent need to accelerating wide woods No. nine eucalyptus oils utilizes.At present, also little to the research of wide woods No. nine Folium eucalypti globueli (Eucalyptus globulus Labill.) oil properties, be particularly also blank substantially for bioactive research.
Summary of the invention
The technical problem to be solved in the present invention overcomes existing defect, provides the application process of a kind of wide woods No. nine eucalyptus leaf essential oils.
Object of the present invention carrys out specific implementation by the following technical programs:
Wide woods No. nine eucalyptus leaf essential oils are as the application of antibacterial medicines.
Preferably, described antibacterial medicines comprises the medicine suppressing Aspergillus flavus, Penicillium citrinum, aspergillus niger, staphylococcus aureus, escherichia coli or bacillus subtilis.
Preferred further, described antibacterial medicines is the medicine suppressing Penicillium citrinum, and its minimal inhibitory concentration is 5mL/L.
Beneficial effect of the present invention:
The ground-breaking application process providing a kind of wide woods No. nine eucalyptus leaf essential oils of the present invention, adopts filter paper enzyme and plate dilution assay method wide woods No. nine eucalyptus leaf essential oils to the bacteriostatic activity of Aspergillus flavus, Penicillium citrinum, aspergillus niger, staphylococcus aureus, escherichia coli and bacillus subtilis etc. 6 kinds for examination microorganism.Wide woods No. nine eucalyptus leaf essential oils all have certain bacteriostatic activity to escherichia coli, bacillus subtilis, staphylococcus aureus, Aspergillus flavus, aspergillus niger and Penicillium citrinum.Quintessence oil is 10mL/L ~ 20mL/L to the minimal inhibitory concentration scope for examination antibacterial, and antibacterial circle diameter scope is 9.5mm ~ 16.8mm.Wherein, quintessence oil is the strongest to staphylococcus aureus inhibitory action, and its minimal inhibitory concentration is 10mL/L.Quintessence oil is 5mL/L ~ 10mL/L to mycete for the minimal inhibitory concentration scope of examination strain, is respectively 9.7mm, 11.7mm and 17.5mm to the antibacterial circle diameter of Aspergillus flavus, aspergillus niger and Penicillium citrinum.In mycete, quintessence oil is the strongest to the bacteriostasis of Penicillium citrinum, and its minimal inhibitory concentration is 5mL/L.Strong by the rejection ability of comparative illustration quintessence oil to the rejection ability comparison antibacterial of mycete.
Detailed description of the invention
Below the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein is only for instruction and explanation of the present invention, is not intended to limit the present invention.
Adopt filter paper enzyme and plate dilution assay method wide woods No. nine eucalyptus leaf essential oils to the bacteriostatic activity of Aspergillus flavus, Penicillium citrinum, aspergillus niger, staphylococcus aureus, escherichia coli and bacillus subtilis etc. 6 kinds for examination microorganism.Wide woods No. nine eucalyptus leaf essential oils all have certain bacteriostatic activity to escherichia coli, bacillus subtilis, staphylococcus aureus, Aspergillus flavus, aspergillus niger and Penicillium citrinum.Quintessence oil is 10mL/L ~ 20mL/L to the minimal inhibitory concentration scope for examination antibacterial, and antibacterial circle diameter scope is 9.5mm ~ 16.8mm.Wherein, quintessence oil is the strongest to staphylococcus aureus inhibitory action, and its minimal inhibitory concentration is 10mL/L.Quintessence oil is 5mL/L ~ 10mL/L to mycete for the minimal inhibitory concentration scope of examination strain, is respectively 9.7mm, 11.7mm and 17.5mm to the antibacterial circle diameter of Aspergillus flavus, aspergillus niger and Penicillium citrinum.In mycete, quintessence oil is the strongest to the bacteriostasis of Penicillium citrinum, and its minimal inhibitory concentration is 5mL/L.Strong by the rejection ability of comparative illustration quintessence oil to the rejection ability comparison antibacterial of mycete.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (3)
1. wide woods No. nine eucalyptus leaf essential oils are as the application of antibacterial medicines.
2. application according to claim 1, is characterized in that: described antibacterial medicines comprises the medicine suppressing Aspergillus flavus, Penicillium citrinum, aspergillus niger, staphylococcus aureus, escherichia coli or bacillus subtilis.
3. application according to claim 2, is characterized in that: described antibacterial medicines is the medicine suppressing Penicillium citrinum, and its minimal inhibitory concentration is 5mL/L.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410761495.XA CN104435130A (en) | 2014-12-12 | 2014-12-12 | Application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410761495.XA CN104435130A (en) | 2014-12-12 | 2014-12-12 | Application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104435130A true CN104435130A (en) | 2015-03-25 |
Family
ID=52882392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410761495.XA Pending CN104435130A (en) | 2014-12-12 | 2014-12-12 | Application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104435130A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113599428A (en) * | 2021-07-27 | 2021-11-05 | 青岛阿郎自然农耕研究所 | Method for reducing aflatoxin B1 by adopting mulberry root bark in traditional processing of dried orange peel |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130101634A1 (en) * | 2011-10-12 | 2013-04-25 | Deerland Enzymes, Inc. | Compositions and methods for reducing microbial overgrowth in the small intestines |
| CN104042675A (en) * | 2014-07-07 | 2014-09-17 | 天津农学院 | Compound agaricus blazei murill polysaccharide composition and application thereof |
-
2014
- 2014-12-12 CN CN201410761495.XA patent/CN104435130A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130101634A1 (en) * | 2011-10-12 | 2013-04-25 | Deerland Enzymes, Inc. | Compositions and methods for reducing microbial overgrowth in the small intestines |
| CN104042675A (en) * | 2014-07-07 | 2014-09-17 | 天津农学院 | Compound agaricus blazei murill polysaccharide composition and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 田玉红等: "广林九号桉叶精油的抑菌活性研究", 《湖北农业科学》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113599428A (en) * | 2021-07-27 | 2021-11-05 | 青岛阿郎自然农耕研究所 | Method for reducing aflatoxin B1 by adopting mulberry root bark in traditional processing of dried orange peel |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103589674B (en) | Bacillus subtilis Pc3 and use of bacillus subtilis Pc3 in preparation of fermentation supernatant for preventing and controlling plant pathogenic fungi | |
| CN105219681A (en) | A kind of bacillus amyloliquefaciens Bacillus amyloliquefaciens D2WM and preparation method and application | |
| CN103461396B (en) | Compound botanical fungiticide, and preparation method and application thereof | |
| Barriuso | Quorum sensing mechanisms in fungi | |
| Chakraborty et al. | Antimicrobial activity of leaf extract of Basilicum polystachyon (L) Moench | |
| CN104642389A (en) | Biocontrol bacterium and pyraclostrobin composition | |
| Rodino et al. | Evaluation of the antimicrobial and antioxidant activity of Sambucus ebulus extract | |
| Ganash et al. | Phenolic acids and biological activities of Coleus forskohlii and Plectranthus barbatus as traditional medicinal plants | |
| CN102381912A (en) | Microbial pesticide preparation for plant protection and growth regulation | |
| CN104435130A (en) | Application of essential oil from leaves of eucalyptus urophylla E.grandis, Guanglin 9 as bacteriostatic drug | |
| CN102687733A (en) | Black locust plant acaricide, preparation method and application thereof | |
| CN104800134A (en) | Preservative for skin care product | |
| CN104642390A (en) | Biocontrol bacterium and azoxystrobin composition | |
| CN103449897A (en) | Antibacterial biological fertilizer | |
| CN103988896A (en) | Prevention and treatment on postharvest diseases of fruits by using glycine betaine-induced culture of pichia caribbica | |
| CN109043290B (en) | Synergist for food biological preservative and using method thereof | |
| CN104398463A (en) | Pure-vegetal mosquito-repellent floral water | |
| BR112012022603A2 (en) | highly productive isopropyl alcohol producing bacteria | |
| CN104823974A (en) | Applications of caffeic acid alkyl ester | |
| CN110771604A (en) | Inhibitor for tobacco bacterial wilt | |
| CN110024783A (en) | A kind of botanical sterilization preparation and its application method for preventing and treating tea tree anthracnose | |
| Stanley et al. | The antimicrobial activity of sclerotia of Pleurotus tuberregium (Osu) on some clinical isolates | |
| CN107549582B (en) | Walnut polypeptide compound used as antibacterial agent | |
| CN110742076A (en) | Application of liquiritin in preventing and treating crop oomycetes and fungal diseases | |
| CN103843821A (en) | Crop pesticide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
| RJ01 | Rejection of invention patent application after publication |